ORLANDO -- The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to studies reported here. More than half of patients with psoriatic ...

In his outstanding lecture identifying drivers of lupus, presented at the 2025 meeting of the Medical Dermatology Society, Jaehyuk Choi, MD, PhD, explained that interferon -- the well-known nemesis of ...

Increased odds of atherosclerotic cardiovascular disease seen in association with cutaneous lupus and systemic lupus, but not psoriasis. HealthDay News — Cutaneous lupus erythematosus (CLE) is ...

Anhidrosis can occur with medical conditions like psoriasis, lupus, and diabetes. Lack of sweat can lead to serious heat-related illnesses like heat stroke. Some people may not sweat enough due to ...

Cancer drug research continues to bring patients targeted therapies for tumors that express specific genetic or biological signatures. This precision oncology approach means a clinician can tailor ...

Many drugs, both old and new, are now being studied in people with lupus. The drugs described below are not a complete list of all the drugs currently in development for lupus, and they may not all ...

Please provide your email address to receive an email when new articles are posted on . Exposure to nitrogen oxides increased risks for rheumatoid arthritis, Sjögren’s and systemic lupus erythematosus ...